Training new investigators is a core mission of the Vasculitis Clinical Research Consortium (VCRC) and of high-priority to the Vasculitis Foundation (VF). The VCRC-VF Fellowship Program has been extremely successful. During the two initial 5-year grant periods, the VCRC recruited and provided salary support for 9 VCRC Fellows for two-year structured fellowships, all of whom remain in academic medicine, are specifically focused on caring for patients with vasculitis, and are engaged in clinical research in vasculitis. The VCRC-VF Fellowship is a structured, mentored training program of up to two years for physician-investigators who have developed an interest in vasculitis and wish to pursue a period of specialized training with an emphasis on translational and patient-oriented clinical investigation. The trainee undertakes the fellowship at one of the VCRC clinical research sites. Fellows who have developed an interest in vasculitis are recruited from Rheumatology, Nephrology, Pulmonology, Neurology, Vascular Medicine/Cardiology or other subspecialties. The Fellowship involves conduct of hypothesis-based clinical research in vasculitis, limited clinical experience focused on care of patients with vasculitis, and coursework directed at acquiring advanced skills in clinical research methodology. We propose to maintain the same careful approach to applicant selection and comprehensive training we have refined in the past decade, but will expand the number of Fellows and the number of VCRC Centers eligible to host VCRC Fellows. The VCRC-VF Fellowship will have additional generous financial support from the VF. The VCRC-VF Fellowship addresses the need to train more physicians in the care of patients with vasculitis and to develop a new generation of vasculitis clinical investigators.
The VCRC-VF Fellowship provides support for a 2-year program to train physicians in the care of patients with vasculitis and to provide the Fellows with additional advanced training in clinical research in vasculitis. This program will be a combine effort of the Vasculitis Clinical Research Consortium and the Vasculitis Foundation.
|Bingham 3rd, Clifton O; Bartlett, Susan J; Merkel, Peter A et al. (2016) Using patient-reported outcomes and PROMIS in research and clinical applications: experiences from the PCORI pilot projects. Qual Life Res 25:2109-16|
|Kermani, Tanaz A; Cuthbertson, David; Carette, Simon et al. (2016) The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis. J Rheumatol 43:1078-84|
|Sy, Alice; Khalidi, Nader; Dehghan, Natasha et al. (2016) Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature. Semin Arthritis Rheum 45:475-82|
|Merkel, Peter A; Manion, Michele; Gopal-Srivastava, Rashmi et al. (2016) The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network. Orphanet J Rare Dis 11:66|
|Tamura, Roy N; Krischer, Jeffrey P; Pagnoux, Christian et al. (2016) A small n sequential multiple assignment randomized trial design for use in rare disease research. Contemp Clin Trials 46:48-51|
|Pagnoux, C; Carette, S; Khalidi, N A et al. (2015) Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts. Clin Exp Rheumatol 33:S-77-83|
|Kermani, Tanaz A; Warrington, Kenneth J; Cuthbertson, David et al. (2015) Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study. J Rheumatol 42:1213-7|
|Hatemi, Gulen; Ozguler, Yesim; Direskeneli, Haner et al. (2015) Current Status, Goals, and Research Agenda for Outcome Measures Development in BehÃ§et Syndrome: Report from OMERACT 2014. J Rheumatol 42:2436-41|
|Aydin, Sibel Zehra; Direskeneli, Haner; Sreih, Antoine et al. (2015) Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12. J Rheumatol 42:2465-9|
|Dejaco, Christian; Oppl, Bastian; Monach, Paul et al. (2015) Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss). PLoS One 10:e0121737|
Showing the most recent 10 out of 59 publications